IP Library › Granted Patent US 7,981,885
Granted Patent B2
US 7,981,885 · App. 11/897,598 · Granted Jul 19, 2011

Compositions for treatment of diseases related to activated lymphocytes

Assignee: Immune Control Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,981,885
App. No.
11/897,598
Granted
Jul 19, 2011
Kind
B2
Abstract

The present invention relates to inhibiting proliferation and inducing apoptosis in activated lymphocytes, including T cells and B cells. The invention also provides compositions and methods for inhibiting proliferation and inducing apoptosis in activated lymphocytes, as well methods for treating diseases associated with activated lymphocytes by administering 5-HT receptor antagonists.

Claims (4)

1. The compound

or a pharmaceutically acceptable salt thereof.

2. A pharmaceutical composition comprising

or a pharmaceutically acceptable salt thereof.

Assignments (2)
MERGER Recorded Oct 26, 2011
From: IMMUNE CONTROL INC.; ARGINETIX, INC.
To: CORRIDOR PHARMACEUTICALS, INC.
Reel/Frame 027121/0692 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 22, 2009
From: ROTH, STEPHEN; BUCK, CLAYTON; SELF, CHRISTOPHER; OLSON, GARY
To: IMMUNE CONTROL INC
Reel/Frame 022724/0792 →
Continuity (2)
Provisional Application 60841771 · Sep 1, 2006
Related Publication 20080132697A1 · Jun 5, 2008